Publication | Closed Access

Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability

Oral BioavailabilityMedicineAntiviral Drug DevelopmentAntiviral ResponseAntiviral TherapyVirologyAntiviral DrugPharmacologyAntiviral Compound